Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis

By sjmartinez • May 23, 2025

Li B, Elsten-Brown J, Li M, Zhu E, Li Z, Chen Y, Kang E, Ma F, Chiang J, Li YR, Zhu Y, Huang J, Fung A, Scarborough Q, Cadd R, Zhou JJ, Chin AI, Pellegrini M, Yang L. Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis. Cell. 2025 May 20:S0092-8674(25)00502-1. doi: 10.1016/j.cell.2025.04.032. Epub ahead of print. PMID: 40403728.

Tags: antidepressants, cancer immunotherapy, Cardiology/Epi, Dermatology, immune checkpoint, intratumoral serotonin axis, PD-1 blockade, Publications, serotonin, serotonin transporter, SSRIs, T cell antitumor immunity, tumor microenvironment, Veterans Administration

Related Posts

FAP Expression in Renal Tumors Assessed by [68Ga]Ga-FAPI-46 PET Imaging and FAP Immunohistochemistry: A Case Series of Six Patients from the Prospective Exploratory Trial NCT04147494

Holzgreve A, Unterrainer LM, Flores K, Lam EC, Mona CE, Czernin J, Shuch BM, Sisk AE Jr, Calais J. FAP Expression in Renal Tumors Assessed[...]

Akebia Saponin D Targeting Ubiquitin Carboxyl-Terminal Hydrolase 4 Promotes Peroxisome Proliferator-Activated Receptor Gamma Deubiquitination and Activation of Brown Adipose Tissue Thermogenesis in Obesity

Chen L, Liu DH, Li YX, Yang S, Jia WH, Peng L, Liu HL, Wang XB, Hu B, Wang YC, Pan C, Lusis AJ, Liu[...]

The relationship between blood eosinophil count and cardiovascular outcomes in prediabetes and diabetes patients with acute coronary syndrome: insights from a large Asian cohort analysis

Feng X, Liu Y, Qin H, Zhao S, Yang J, Yang S, Zhou Z, Liu Y, Wang Z, Shi D, Zhou Y, Guo Q. The[...]